Gynecology Clinical Trials

LF111-401 (Exeltis)

Condition: Bone Mineral Density (BMD)

Type of Research: Interventional

Principal Investigator: Mariel Focseneanu, MD

The LF111-401 study will investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral density (BMD) in adolescent and adult women in comparison with non-users of hormonal contraceptive methods.

Email: CRU@chkd.org
Phone: (757) 668-5416